Laura Orsolini1,2, Irena Rojnić Palavra3, Gabriele Duccio Papanti4, Matej Potočan5, Diego Quattrone6, Matis Martens7, Sandra Sklenářová8,9, Jonna Levola10, Leslie Grichy11, Sean Naughton12, Indre Kotryna Grinevičiene13, Jelly Petra Kuiters14, Tomasz M Gondek15, Anca-Livia Panfil16, Milica M Borovcanin17, Alberto San Roman Uria18, Ewelina Biskup19,20, Ekin Sönmez Güngör21, Marisa Casanova Dias22,23, Sonila Tomori24, Visnja Banjac25, Petra Marinova-Djambazova26, Mariana Pinto da Costa27,28,29. 1. Unit of Clinical Psychiatry, Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy. 2. Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom. 3. Psychiatric Hospital Sveti Ivan, Zagreb, Croatia. 4. Mental Health Department, Friuli Venezia Giulia, Italy. 5. Psychiatric Hospital Begunje, Begunje na Gorenjskem, Slovenia. 6. Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. 7. Vaasa Central Hospital, Psychiatry Outpatient Clinic, Vaasa, Finland. 8. Department of Child Psychiatry, Charles University Second Faculty of Medicine, Motol University Hospital, Prague, Czechia. 9. Institute of Neuropsychiatric Care, Prague, Czechia. 10. Psychiatry, Hospital District of Helsinki and Uusimaa, Helsinki, Finland. 11. Adult Partial Hospitalization Program, Department of Psychiatry, Universitary Hospital Louis Mourier, Colombes, France. 12. Health Service Executive, Dublin, Ireland. 13. Vilnius City Mental Health Center, Vilnius, Lithuania. 14. Lentis, Zuidlaren, Netherlands. 15. European Psychiatric Association-Early Career Psychiatrists Committee, Wroclaw, Poland. 16. County Emergency Clinical Hospital, Pius Brînzeu, Liaison Psychiatry, Timisoara, Romania. 17. Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia. 18. Psychiatric Inpatient Unit, Department of Psychiatry, Hospital Universitario Nuestra Señora de Valme, Seville, Spain. 19. Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy. 20. School of Clinical Medicine, Shanghai University of Medicine and Health Sciences, Shanghai, China. 21. University of Health Sciences, Erenköy Mental Health and Neurological Diseases Training and Research Hospital, Istanbul, Turkey. 22. National Centre for Mental Health, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom. 23. Section of Women's Mental Health, King's College, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom. 24. University Hospital Center "Mother Theresa", Tirana, Albania. 25. Clinic of Psychiatry, University Clinical Center of the Republic of Srpska, Banjaluka, Bosnia and Herzegovina. 26. Department of Psychiatry in Medical University, University Hospital "Aleksandrovska", Sofia, Bulgaria. 27. Unit for Social and Community Psychiatry, World Health Organization (WHO) Collaborating Centre for Mental Health Services Development, Queen Mary University of London, London, United Kingdom. 28. Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal. 29. Hospital de Magalhães Lemos, Porto, Portugal.
Abstract
Background: Although psychoactive substance use disorders (PSUDs) are a domain of mental health, addiction psychiatry is only formally recognized as a subspecialty in a few European countries, and there is no standardized training curriculum. Methods: A 76-item questionnaire was developed and disseminated through an online anonymous data-collecting system and hand-to-hand amongst psychiatric trainees from the 47 European countries of the Council of Europe plus Israel and Belarus. Results: 1,049/1,118 psychiatric trainees from 30 European countries completed the questionnaire. Fifty-nine-point nine percent of trainees stated to have training in addictions. Amongst the trainees who described having training in addictions, 43% documented a not well-structured training and 37% an unsatisfactory training, mainly due to poor acquired knowledge. Overall, 97% of trainees stated that addiction represents a core curriculum for their training. Overall, general adult psychiatric trainees reported a better knowledge in addictions, compared to trainees in child and adolescent psychiatry. Conclusion: Despite a growing spread of PSUDs in European countries, addiction psychiatry is a relatively poorly trained field within psychiatry training programs. Further research should investigate reasons for poor training and timings of the educational activities to optimize experiential education training in addiction psychiatry.
Background: Although psychoactive substance use disorders (PSUDs) are a domain of mental health, addiction psychiatry is only formally recognized as a subspecialty in a few European countries, and there is no standardized training curriculum. Methods: A 76-item questionnaire was developed and disseminated through an online anonymous data-collecting system and hand-to-hand amongst psychiatric trainees from the 47 European countries of the Council of Europe plus Israel and Belarus. Results: 1,049/1,118 psychiatric trainees from 30 European countries completed the questionnaire. Fifty-nine-point nine percent of trainees stated to have training in addictions. Amongst the trainees who described having training in addictions, 43% documented a not well-structured training and 37% an unsatisfactory training, mainly due to poor acquired knowledge. Overall, 97% of trainees stated that addiction represents a core curriculum for their training. Overall, general adult psychiatric trainees reported a better knowledge in addictions, compared to trainees in child and adolescent psychiatry. Conclusion: Despite a growing spread of PSUDs in European countries, addiction psychiatry is a relatively poorly trained field within psychiatry training programs. Further research should investigate reasons for poor training and timings of the educational activities to optimize experiential education training in addiction psychiatry.
Authors: Astri Parawita Ayu; Arnt F A Schellekens; Shelly Iskandar; Lucas Pinxten; Cor A J De Jong Journal: Eur Addict Res Date: 2015-05-05 Impact factor: 3.015
Authors: Georg Schomerus; Michael Lucht; Anita Holzinger; Herbert Matschinger; Mauro G Carta; Matthias C Angermeyer Journal: Alcohol Alcohol Date: 2010-12-18 Impact factor: 2.826
Authors: Makeida B Koyi; Archana Nelliot; Dean MacKinnon; Darius A Rastegar; Michael Fingerhood; Anika Alvanzo; Leonard Feldman; Karin J Neufeld Journal: Acad Psychiatry Date: 2017-04-06
Authors: Amber L Bahorik; Derek D Satre; Andrea H Kline-Simon; Constance M Weisner; Cynthia I Campbell Journal: J Addict Med Date: 2017 Jan/Feb Impact factor: 3.702
Authors: Amy Peacock; Janni Leung; Sarah Larney; Samantha Colledge; Matthew Hickman; Jürgen Rehm; Gary A Giovino; Robert West; Wayne Hall; Paul Griffiths; Robert Ali; Linda Gowing; John Marsden; Alize J Ferrari; Jason Grebely; Michael Farrell; Louisa Degenhardt Journal: Addiction Date: 2018-06-04 Impact factor: 6.526